Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 10/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | SMYD2 | Q9NRG4 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.36 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.36 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31246231 | 0.90 | SMYD2 (0.39) | PPARDPPARASMYD2CYP3A4HTT | |
| SCHEMBL28950526 | 0.88 | GPR84 (0.43) | SMYD2CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL28950527 | 0.88 | GPR84 (0.43) | SMYD2CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL29627016 | 0.87 | FAAH (0.49) | SMYD2CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL19582827 | 0.86 | FAAH (0.36) | SMYD2CYP3A4HTTSMN1; SMN2HDAC3 | |
| SCHEMBL29113324 | 0.84 | MMP2 (0.41) | — | |
| SCHEMBL18082177 | 0.83 | SMYD2 (0.38) | PPARDPPARASMYD2CYP3A4HTT | |
| SCHEMBL18641636 | 0.83 | SMYD2 (0.40) | SMYD2CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL18664981 | 0.83 | SMYD2 (0.40) | SMYD2CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL17747703 | 0.82 | CPA1 (0.41) | SMYD2CYP3A4HTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260102373-A1 | LYMPH DIRECTING PRODRUGS | MONASH UNIVERSITY (AU) | 2026-04-16 | — | — | US | disclosed |
| US-20250352510-A1 | LYMPH DIRECTING PRODRUGS | MONASH UNIVERSITY (AU) | 2025-11-20 | — | — | US | disclosed |
| US-20250213522-A1 | LYMPH DIRECTING PRODRUGS | MONASH UNIVERSITY (AU) | 2025-07-03 | — | — | US | disclosed |
| EP-4578865-A2 | LYMPH DIRECTING PRODRUGS | Monash University (AU) | 2025-07-02 | — | — | EP | disclosed |
| EP-3180349-B1 | LYMPH DIRECTING PRODRUGS AND THERAPEUTIC USES THEREOF | UNIV MONASH (AU) | 2025-03-12 | — | — | EP | disclosed |
| CN-117164657-A | Prodrugs of directed lymphatics | 莫纳什大学 | 2023-12-05 | — | — | CN | disclosed |
| CN-117088931-A | Prodrugs of directed lymphatics | 莫纳什大学 | 2023-11-21 | — | — | CN | disclosed |
| CN-106715456-B | Prodrugs of directed lymphatics | 莫纳什大学 | 2023-08-29 | — | — | CN | disclosed |
| US-20220211664-A1 | LYMPH DIRECTING PRODRUGS | MONASH UNIVERSITY (AU) | 2022-07-07 | — | — | US | disclosed |
| US-11311512-B2 | Lymph directing prodrugs | MONASH UNIVERSITY (AU) | 2022-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220211664-A1 | LYMPH DIRECTING PRODRUGS | LTA, ABCB11, LYN | PPARD 3381/4885PPARA 2230/4885SMYD2 2866/4885 |
| US-11311512-B2 | Lymph directing prodrugs | LTA, ABCB11, LYN | PPARD 3381/4885PPARA 2230/4885SMYD2 2866/4885 |
| US-20260102373-A1 | LYMPH DIRECTING PRODRUGS | MALT1, CES1, LIPA | PPARD 1891/4885PPARA 994/4885SMYD2 1500/4885 |
| US-20250213522-A1 | LYMPH DIRECTING PRODRUGS | LTA, ABCB11, LYN | PPARD 3381/4885PPARA 2230/4885SMYD2 2866/4885 |
| US-20250352510-A1 | LYMPH DIRECTING PRODRUGS | LTA, ABCB11, LYN | PPARD 3381/4885PPARA 2230/4885SMYD2 2866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.